<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Isosceles Pharmaceuticals</title>
    <link>https://www.biospace.com/employer/3076410/isosceles-pharmaceuticals</link>
    <description>Isosceles Pharmaceuticals</description>
    <language>en-US</language>
    <lastBuildDate>Wed, 05 May 2021 15:16:05 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/3076410/isosceles-pharmaceuticals.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer</title>
      <link>https://www.biospace.com/isosceles-pharmaceuticals-inc-appoints-william-d-humphries-as-its-chief-executive-officer</link>
      <description>Isosceles Pharmaceuticals Inc. today announced the appointment of William D. Humphries as its Chief Executive Officer.</description>
      <pubDate>Wed, 05 May 2021 15:16:05 GMT</pubDate>
      <guid>https://www.biospace.com/isosceles-pharmaceuticals-inc-appoints-william-d-humphries-as-its-chief-executive-officer</guid>
    </item>
    <item>
      <title>Isosceles Pharmaceuticals Signs Non-Binding Letter of Intent With a Strategic Partner for Phase 1 Development of Its Proprietary Synthetic Cannabidiol Intravenous Product</title>
      <link>https://www.biospace.com/isosceles-pharmaceuticals-signs-non-binding-letter-of-intent-with-a-strategic-partner-for-phase-1-development-of-its-proprietary-synthetic-cannabidiol-intravenous-product</link>
      <description>Isosceles Pharmaceuticals, Inc. has announced the execution of a non-binding letter of intent with a strategic partner for the phase 1 development of the Company's intravenous product, IPI 201.</description>
      <pubDate>Mon, 31 Oct 2022 12:36:50 GMT</pubDate>
      <guid>https://www.biospace.com/isosceles-pharmaceuticals-signs-non-binding-letter-of-intent-with-a-strategic-partner-for-phase-1-development-of-its-proprietary-synthetic-cannabidiol-intravenous-product</guid>
    </item>
  </channel>
</rss>
